Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05316727 · ClinicalTrials.gov registry record

Electronic Nicotine Delivery Devices and Potential Progression to Acute Lung Injury

A clinical trial, sponsored by University of Pittsburgh.

Completed
Registry status
101
Enrollment target

NCT05316727 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 101 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05316727 has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
101 participants
Enrollment target

Study Summary

This is an observational - data and specimen collection study. There have been increasing reports of vaping-induced lung injury, including severe lung injury and rare cases of death. The mechanism by which vaping contributes to lung injury in susceptible persons is unknown, as is impact on chronic lung disease. The investigators aim to identify individuals with chronic electronic nicotine delivery device (ENDD) exposure and matched controls within our ongoing cohort of HIV+ and HIV-uninfected individuals, collect PFT data, bank respiratory and stool samples and collect clinical data for studies of clinical risk, inflammation, biomarkers, and the microbiome in the identification and modification of risk of progression to lung injury or chronic pulmonary disease.

Trial Details

FieldValue
Enrollment Target 101 participants
Start Date 2021-11-15
Est. Completion 2024-12-01

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT05316727

The ClinicalTrials.gov registry entry for NCT05316727 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT05316727 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05316727 about?

NCT05316727 is a clinical study titled "Electronic Nicotine Delivery Devices and Potential Progression to Acute Lung Injury". This is an observational - data and specimen collection study. There have been increasing reports of vaping-induced lung injury, including severe lung injury and rare cases of death. The mechanism by which vaping contributes to lung injury in susceptible persons is unknown, as is impact on chronic l...

What is the current status of trial NCT05316727?

This trial is currently completed. The enrollment target is 101 participants. The study started on 2021-11-15. Estimated completion is 2024-12-01.

Who is sponsoring clinical trial NCT05316727?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.